ArticleThe Journal of experimental medicine2015

IRAK4 inhibition to shut down TLR signaling in autoimmunity and MyD88-dependent lymphomas.

Ralf KüppersPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.